Valsartan and amlodipine combination therapy for the treatment of hypertension
Date of this Version
Studies have consistently shown that most patients with hypertension require two or more antihypertensive agents to control their blood pressure. This had led to the introduction of fixed-dose combination therapies that enable two antihypertensive drugs to be administered in the one tablet. These fixed-dose combinations, typically of ACE inhibitors or angiotensin receptor antagonists combined with diuretics, have become commonly used therapies in Australia because they offer the promise of greater patient acceptance and compliance than the individual drugs given alone. However, recent studies have suggested that either an ACE inhibitor or an angiotensin receptor antagonist combined with a calcium channel blocker may provide better pressure control and superior outcomes than combinations that contain a diuretic.
This document is currently not available here.
This document has been peer reviewed.